Alan F. Denenberg

Davis Polk advised the sole bookrunning manager in connection with the public offering of 3,500,000 shares of the common stock of Coherus BioSciences, Inc. at a price to the public of …

Davis Polk advised the joint book-running managers in connection with a $2.75 billion SEC-registered debt offering by Intel Corporation, consisting of $500 million of its 1.700% senior…

Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750 ordinary shares of Theravance Biopharma, Inc. The ordinary shares…

Davis Polk advised the lead dealer manager for Alphabet Inc. in connection with the offers by Alphabet to exchange any and all outstanding $1 billion 3.625% notes due 2021 and $1 billion 3…

Davis Polk advised the representatives of the several underwriters, in connection with a secondary offering of 18,975,000 shares of Class A common stock of GoDaddy Inc. by certain of…

Davis Polk is advising JP Morgan as financial adviser to MTS Systems Corporation in connection with its $580 million acquisition of PCB Group, Inc. The closing of the transaction, which is…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Torchmark Corporation of $300 million aggregate principal amount of 6.125% junior subordinated debentures…

Davis Polk is advising Solazyme, Inc. (SZYM) in connection with its private placement of approximately $28 million of its Series A convertible preferred stock to Glenhill Capital Advisors…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by NuVasive, Inc. (“NuVasive”) of $650 million aggregate principal amount of its 2.25% convertible senior…

Davis Polk advised the joint book-running managers on a $7 billion SEC-registered debt offering by Cisco Systems, Inc., consisting of $1 billion of floating-rate notes due February 21, 2018…